MedTrace Logo

Study of Etoricoxib for the Treatment of Muscle Pain and Inflammation Induced by Eccentric Exercise

NCT01271348 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2011-11-01

No results posted yet for this study

Summary

Comparison of the effect of etoricoxib to placebo on muscle pain caused by eccentric contractions

Conditions

  • Muscle Pain

Interventions

DRUG

Etoricoxib

Etoricoxib film tablet, 90 mg, q.d.

DRUG

placebo

Placebo tablet, q.d.

Sponsors & Collaborators

  • X-pert Med GmbH

    lead INDUSTRY

Principal Investigators

  • Matthias Rother, M.D. · Director Clinical Operations

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01271348 on ClinicalTrials.gov